A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Seagen Inc.
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Travera Inc
Eli Lilly and Company
National Cancer Institute (NCI)
EvolveImmune United, Inc
OncoC4, Inc.
Bayer
AstraZeneca
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Pfizer
IDEAYA Biosciences
Aulos Bioscience, Inc.
Arcus Biosciences, Inc.
AstraZeneca
Memorial Sloan Kettering Cancer Center
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Imperial College London
Pfizer
Rondo Therapeutics
Origin Sciences
Centre Oscar Lambret
UMC Utrecht
City of Hope Medical Center
ViroMissile, Inc.
AstraZeneca
Tizona Therapeutics, Inc
Tasca Therapeutics
Pilatus Biosciences Inc
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Brigham and Women's Hospital
Baylor College of Medicine
Jonsson Comprehensive Cancer Center
University of Colorado, Denver
MacroGenics
Institut Bergonié
City of Hope Medical Center
xCures
Daiichi Sankyo
University of Nebraska
Boehringer Ingelheim
Adela, Inc
Second Life Therapeutics